Over the last year there has been increasing awareness of the inequalities in the American healthcare system. At every level there is evidence of bias, discrimination and unequal access to the best care. Sometimes unequal access to any care. That is, hopefully, changing but only if the new awareness is matched with action. At the … Continue reading Physicians and patient advocates on the front lines of the fight for a more equitable health system
World Stem Cell Summit
‘Right To Try’ laws called ‘Right To Beg’ by Stem Cell Advocates
In recent years, ‘Right to Try’ laws have spread rapidly across the US, getting approved in 32 states, with at least three more states trying to pass their own versions. The organization behind the laws says they serve a simple purpose: ‘Right To Try’ allows terminally ill Americans to try medicines that have passed Phase … Continue reading ‘Right To Try’ laws called ‘Right To Beg’ by Stem Cell Advocates
Why Goldilocks could provide the answer to changing the way FDA regulates stem cells
One of the hottest topics of the past year in regenerative medicine has been the discussion about the need for regulatory reform at the Food and Drug Administration (FDA) so it’s no surprise that topic was the subject of the first main panel discussion at the 2016 World Stem Cell Summit in West Palm Beach, … Continue reading Why Goldilocks could provide the answer to changing the way FDA regulates stem cells
The Critical Role of Patient Advocates in Accelerating Stem Cell Cures
At CIRM, our goal is to bring stem cell therapies to patients with unmet medical needs, and we do that by funding the most promising and innovative research in regenerative medicine. A critical component of this goal is to support our patient advocates and make sure that their voices are heard. At this year’s World … Continue reading The Critical Role of Patient Advocates in Accelerating Stem Cell Cures
Why “Right to Try” laws are more feel good than do good
L to R: Don Gibbons, CIRM; Jeanne Loring; Beth Roxland; Aaron Levine In the last few years some 24 states have approved so-called “Right to Try” laws. These are intended to give terminally ill patients faster and easier access to experimental therapies. But a panel of experts at the World Stem Cell Summit in Atlanta … Continue reading Why “Right to Try” laws are more feel good than do good
The bottom line: stem cell therapies will never be widely available if insurers won’t pay for them
The second session of the World Stem Cell Summit in Atlanta moved past all the promising science and right to the nitty-gritty of making cell-based therapies common. Four panelists reminded the audience that while they too are super excited by the potential for this field, unless folks developing therapies think about reimbursement early those therapies … Continue reading The bottom line: stem cell therapies will never be widely available if insurers won’t pay for them
Call to Action by FDA at World Stem Cell Summit
FDA Deputy Commissioner Dr. Robert Califf talking at the World Stem Cell Summit The World Stem Cell Summit annual conference in Atlanta kicked off today with a clarion call from Dr. Robert Califf, the Deputy Commissioner for the Food and Drug Administration. He told the audience: “We want you to accelerate translation to produce safe … Continue reading Call to Action by FDA at World Stem Cell Summit
A scientific conference we can all enjoy
Scientific conferences are fascinating events. You get a chance to mingle with some of the leading researchers and thinkers in the field, and to learn about the latest advances. But, to be honest, for those of us who don’t have a scientific background, they can also be a little bit intimidating. That’s where the World … Continue reading A scientific conference we can all enjoy
Stem cells and professional sports: a call for more science and less speculation
In the world of professional sports, teams invest tens of millions of dollars in players. Those players are under intense pressure to show a return on that investment for the team, and that means playing as hard as possible for as long as possible. So it’s no surprise that players facing serious injuries will often … Continue reading Stem cells and professional sports: a call for more science and less speculation
World Stem Cell Summit: The environment stem cells find themselves in after transplant really matters
On Friday’s closing day of the 2014 World Stem Cell Summit a panel of three researchers working on neurodegenerative diseases drove home the importance of paying attention to the environment that surrounds stem cells after transplant. CIRM grantee Evan Snyder from the Sanford-Burnham Institute noted that most of the neurologic diseases people are looking at … Continue reading World Stem Cell Summit: The environment stem cells find themselves in after transplant really matters